Burt's Bees skin care products may be a effective as an adjunct to prescription therapy in the management of rosacea, according to data published in the February issue of Journal of Drugs in Dermatology which was reported at the American Academy of Dermatology Annual Meeting this month.
How was the 2019 Dermatology Hall of Fame Executive Board appointed? Find out in this article.
In this table, we highlight frequently asked questions about the staging, treatment and surveillance of early-stage melanoma.
The Dermatology Hall of Fame was established to formally honor the memory and contributions of individual physicians and the revolutionary ideas that have refined the practice of dermatology and continue to inspire, inform and improve treatment. Learn more in this article.
Mindful of all dermatology specialty areas, the Dermatology Hall of Fame nomination process is guided by specific categories and criteria, which we've detailed in this article.
A recent survey asks dermatologists who treat patients with moderate to severe psoriasis about the greatest unmet needs of this patient group. Here's what physicians had to say.
The Food and Drug Administration(FDA) approved in December a new drug application for Tolsura (SUBA-itraconazole), a new formulation of itraconazole for the treatment of systemic fungal infections in adults.
Novel therapeutic recently completed phase three CAMP-1 and CAMP-2 pivotal trials, demonstrating statistically significant improvements in patients with molluscum contagiosum.
The FDA has approved STP705, an siRNA (small interfering RNA) therapeutic for in situ Squamous Cell Carcinoma Nonmelanoma Skin Cancer (NMSC), to proceed with phase two clinical trials.
Vyome Therapeutics Inc. announced in January that it secured $22 million in financing to, in part, support the development of its lead molecule, VB 1953, through phase two clinical trials for moderate to severe acne.
This week the Dermatology Hall of Fame announced its plan to recognize its inductees in Washington, D.C. on February 28, 2019.
In this table, we highlight some of the forthcoming changes to the Medicare Physician Fee Schedule (PFS) from the Centers for Medicare & Medicaid Services (CMS).
In this article, we take a look at the future of dermatology, including the rise of medical devices and drug costs.
The FDA has reversed a long-standing guidance stating that sponsors of clinical trials for atopic dermatitis (AD) in pediatrics need not start the trial in adults first. Here's what you need to know.
Asana BioSciences announced that the U.S. Food and Drug Administration granted fast-track designation for the investigational ASN002, an oral treatment for moderate-to-severe atopic dermatitis. Learn more in this article.
Sandoz, a division of Novartis, announced that the U.S. Food and Drug Administration approved its biosimilar, adalimumabadaz (Hyrimoz, Novartis AG).
The cost of clinical trials to get a dermatology drug to market may cost as much as $25 million, which is slightly above a median of $19 million, according to the latest research.
The American Academy of Dermatology annual meeting will be held from March 1-5 in Washington, D.C.
The National Psoriasis Foundation and the National Eczema Association have awarded Procter & Gamble’s Tide Free and Gentle Liquid Laundry Detergent and Tide PODS Free and Gentle Laundry Detergent a “Seal of Recognition” and “Seal of Acceptance” for people with eczema or sensitive skin.
Image IQ: An 8-year-old girl with a sore throat, deep red tongue, fever and a petechial rash. What’s your diagnosis?
Before 2018 comes to a close, we wanted to say thank you to our readers from everyone here at Dermatology Times. As a thank you, we have compiled a list of the topics and issues you found most compelling throughout the year. Enjoy this slideshow - and see you in 2019!
We've gathered our latest and greatest articles on excessive sweating so you can sit back and relax over the holiday. From a new topical to Botox to treatments yet to come, our slideshow contains all you need to know about novel hyperhidrosis treatments.
The Orlando Dermatology Aesthetic & Clinical Conference (ODAC), formerly known as Orlando Derm, is scheduled for January 18-21 at the JW Marriott in Orlando.
Crown Laboratories has acquired Bellus Medical, allowing the firm to secure a variety of noninvasive aesthetic products, according to a company news release.
Almirall has closed on an agreement to acquire Allergan’s medical dermatology unit in the United States for $550 million.
The U.S. Food and Drug Administration has approved clearance for a new acne treatment that selectively targets sebaceous glands, according to a news release.
Proscia Inc., a digital technology company specializing in the development of artificial intelligence applications and software for digital pathology, recently secured $8.3 million in an initial round of financing.
We've gathered eight of our most interesting Legal Eagle articles from 2018, in which Dr. David J. Goldberg helps navigate some of the most complicated legal questions facing dermatologists today.
